Edap Tms (EDAP) to Release Earnings on Thursday

Edap Tms (NASDAQ:EDAP) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 16th. Analysts expect Edap Tms to post earnings of ($0.10) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Edap Tms (NASDAQ:EDAP) last issued its earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.13). The business had revenue of $21.27 million for the quarter, compared to analysts’ expectations of $21.30 million. Edap Tms had a negative return on equity of 34.33% and a negative net margin of 35.03%. On average, analysts expect Edap Tms to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Edap Tms Price Performance

EDAP opened at $7.10 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.84 and a quick ratio of 2.30. Edap Tms has a 12 month low of $3.60 and a 12 month high of $12.09. The stock has a market capitalization of $263.44 million, a P/E ratio of -11.27 and a beta of 0.65. The business has a 50 day simple moving average of $7.42 and a 200-day simple moving average of $6.30.

Analyst Upgrades and Downgrades

EDAP has been the subject of a number of recent analyst reports. StockNews.com downgraded Edap Tms from a “hold” rating to a “sell” rating in a report on Friday, May 3rd. HC Wainwright raised their price objective on shares of Edap Tms from $16.00 to $19.00 and gave the company a “buy” rating in a research note on Monday, April 1st.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.